Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Islets Langerhans”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03004612
What this trial is testing

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

Who this might be right for
Prediabetic StateInsulin Resistance
Universidad de Guanajuato 144
Testing effectiveness (Phase 2)WithdrawnNCT00784966
What this trial is testing

Islet After Kidney Transplant for Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Virginia Commonwealth University
Not applicableStudy completedNCT03775681
What this trial is testing

Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders

Who this might be right for
Bile Duct DisorderEndocrine Pancreas Disorder
M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)Looking for participantsNCT06881992
What this trial is testing

Ersodetug in Patients With Tumor Hyperinsulinism

Who this might be right for
Tumor Hyperinsulinism (Tumor HI)
Rezolute 16
Not applicableStudy completedNCT03967951
What this trial is testing

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Who this might be right for
Pancreatic Neuroendocrine Tumor
Francesco De Cobelli 70
Not applicableNot Yet RecruitingNCT07494474
What this trial is testing

Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD

Who this might be right for
Autoimmune Thyroid Disease
Nanjing Medical University 834
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Not applicableLooking for participantsNCT05746182
What this trial is testing

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Who this might be right for
Pancreatic Neuroendocrine Neoplasm
University of California, San Francisco 300
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT00027638
What this trial is testing

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+1 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT05171517
What this trial is testing

Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy

Who this might be right for
Pancreatic CarcinomaPancreatic Neuroendocrine TumorAutoimmune Pancreatitis+1 more
Peking Union Medical College Hospital 200
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Not applicableLooking for participantsNCT06725693
What this trial is testing

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Who this might be right for
GLP1-R-related DiseaseTumorInsulinoma+1 more
Tianjin Medical University 500
Early research (Phase 1)Looking for participantsNCT06663072
What this trial is testing

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine Tumor
University of Chicago 25
Not applicableStudy completedNCT05662267
What this trial is testing

Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.

Who this might be right for
type1diabetesRenal FailureEnd Stage Renal Disease
University Hospital, Lille 327
Testing effectiveness (Phase 2)WithdrawnNCT04915144
What this trial is testing

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorPulmonary Carcinoid Tumor+4 more
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Active Not RecruitingNCT05247905
What this trial is testing

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorUnresectable Pancreatic Neuroendocrine Carcinoma
Alliance for Clinical Trials in Oncology 31
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT02872571
What this trial is testing

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

Who this might be right for
Disorder of Endocrine Pancreas
University Hospital, Lille 35
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Next Page